Works (5)

Updated: August 16th, 2023 21:17

2008 journal article

Characterization of normal tissue complications in 51 dogs undergoing definitive pelvic region irradiation


By: J. Arthur n, M. Kleiter*, D. Thrall n & A. Pruitt n

co-author countries: Austria 🇦🇹 United States of America 🇺🇸
author keywords: dog; radiation therapy; normal tissue complication; rectal toxicity
MeSH headings : Animals; Colonic Neoplasms / radiotherapy; Colonic Neoplasms / veterinary; Dog Diseases / epidemiology; Dog Diseases / radiotherapy; Dogs; Female; Male; Necrosis / pathology; Necrosis / veterinary; North Carolina / epidemiology; Pedigree; Pelvis / pathology; Prevalence; Radiation Injuries / epidemiology; Radiation Injuries / veterinary; Radiotherapy Dosage / veterinary; Retrospective Studies
Source: Web Of Science
Added: August 6, 2018

2006 journal article

A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker


By: M. Kleiter n, D. Thrall n, D. Malarkey*, X. Ji*, D. Lee*, S. Chou*, J. Raleigh*

co-author countries: Austria 🇦🇹 United States of America 🇺🇸
author keywords: hypoxia; pimonidazole; CCI-103F; differential metabolism; pH
MeSH headings : Administration, Oral; Animals; Area Under Curve; Cell Hypoxia; Cell Line; Cricetinae; Cricetulus; Dog Diseases / metabolism; Dogs; Feasibility Studies; Hydrogen-Ion Concentration; Injections, Intravenous; Neoplasms / metabolism; Neoplasms / veterinary; Nitroimidazoles / administration & dosage; Nitroimidazoles / pharmacokinetics
Source: Web Of Science
Added: August 6, 2018

2006 journal article

A tracer dose of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratumoral Doxil extravasation

CLINICAL CANCER RESEARCH, 12(22), 6800–6807.

By: M. Kleiter*, D. Yu, L. Mohammadian*, N. Niehaus*, I. Spasojevic*, L. Sanders*, B. Viglianti*, P. Yarmolenko* ...

co-author countries: Canada 🇨🇦 United States of America 🇺🇸
MeSH headings : Animals; Antibiotics, Antineoplastic / pharmacokinetics; Antibiotics, Antineoplastic / therapeutic use; Combined Modality Therapy / methods; Diagnostic Imaging / methods; Dose-Response Relationship, Drug; Doxorubicin / pharmacokinetics; Doxorubicin / therapeutic use; Drug Carriers / administration & dosage; Feasibility Studies; Female; Fibrosarcoma / therapy; Hyperthermia, Induced / methods; Liposomes / administration & dosage; Liposomes / pharmacokinetics; Radioactive Tracers; Rats; Technetium Tc 99m Exametazime / administration & dosage; Thigh / radiation effects; Tumor Cells, Cultured; Xenograft Model Antitumor Assays
Source: Web Of Science
Added: August 6, 2018

2004 article

Expression of cyclooxygenase-2 in canine epithelial nasal tumors


By: M. Kleiter n, D. Malarkey*, D. Ruslander n & D. Thrall n

co-author countries: United States of America 🇺🇸
author keywords: canine; cyclooxygenase-2; nasal tumors; radiation therapy
MeSH headings : Adenocarcinoma / enzymology; Adenocarcinoma / veterinary; Animals; Carcinoma, Squamous Cell / enzymology; Carcinoma, Squamous Cell / veterinary; Case-Control Studies; Combined Modality Therapy; Cyclooxygenase 2; Dog Diseases / drug therapy; Dog Diseases / enzymology; Dog Diseases / radiotherapy; Dogs; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Isoenzymes / metabolism; Nose Neoplasms / enzymology; Nose Neoplasms / veterinary; Prostaglandin-Endoperoxide Synthases / metabolism; Records / veterinary; Retrospective Studies
Source: Web Of Science
Added: August 6, 2018

2003 journal article

Renal amyloidosis in a dog with chronic Ehrlichiosis

Schweizer Archiv Fur Tierheilkunde, 145(10), 482–485.

By: N. Luckschander, M. Kleiter & M. Willmann

Source: NC State University Libraries
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.